473 related articles for article (PubMed ID: 30355585)
1. Immune regulation of metastasis: mechanistic insights and therapeutic opportunities.
Blomberg OS; Spagnuolo L; de Visser KE
Dis Model Mech; 2018 Oct; 11(10):. PubMed ID: 30355585
[TBL] [Abstract][Full Text] [Related]
2. The immune system in cancer metastasis: friend or foe?
Janssen LME; Ramsay EE; Logsdon CD; Overwijk WW
J Immunother Cancer; 2017 Oct; 5(1):79. PubMed ID: 29037250
[TBL] [Abstract][Full Text] [Related]
3. Immune cell promotion of metastasis.
Kitamura T; Qian BZ; Pollard JW
Nat Rev Immunol; 2015 Feb; 15(2):73-86. PubMed ID: 25614318
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine-Based Immunotherapy for the Treatment of Cancer Metastasis.
Zhang P; Zhai Y; Cai Y; Zhao Y; Li Y
Adv Mater; 2019 Dec; 31(49):e1904156. PubMed ID: 31566275
[TBL] [Abstract][Full Text] [Related]
5. Immune cells as mediators of solid tumor metastasis.
DeNardo DG; Johansson M; Coussens LM
Cancer Metastasis Rev; 2008 Mar; 27(1):11-8. PubMed ID: 18066650
[TBL] [Abstract][Full Text] [Related]
6. Myeloid Cells in Metastasis.
Swierczak A; Pollard JW
Cold Spring Harb Perspect Med; 2020 May; 10(5):. PubMed ID: 31548218
[TBL] [Abstract][Full Text] [Related]
7. Inflammation-mediated promotion of invasion and metastasis.
Solinas G; Marchesi F; Garlanda C; Mantovani A; Allavena P
Cancer Metastasis Rev; 2010 Jun; 29(2):243-8. PubMed ID: 20414701
[TBL] [Abstract][Full Text] [Related]
8. Metastases in immune-mediated dormancy: a new opportunity for targeting cancer.
Romero I; Garrido F; Garcia-Lora AM
Cancer Res; 2014 Dec; 74(23):6750-7. PubMed ID: 25411345
[TBL] [Abstract][Full Text] [Related]
9. Control of Metastasis by NK Cells.
López-Soto A; Gonzalez S; Smyth MJ; Galluzzi L
Cancer Cell; 2017 Aug; 32(2):135-154. PubMed ID: 28810142
[TBL] [Abstract][Full Text] [Related]
10. Role of miRNAs in human cancer metastasis: Implications for therapeutic intervention.
Jafri MA; Al-Qahtani MH; Shay JW
Semin Cancer Biol; 2017 Jun; 44():117-131. PubMed ID: 28188828
[TBL] [Abstract][Full Text] [Related]
11. Metastasis as a systemic disease: molecular insights and clinical implications.
Alečković M; McAllister SS; Polyak K
Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):89-102. PubMed ID: 31202687
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
13. A mathematical model for the immune-mediated theory of metastasis.
Rhodes A; Hillen T
J Theor Biol; 2019 Dec; 482():109999. PubMed ID: 31493486
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia and the Tumor Secretome.
Liu Y; Ciotti GE; Eisinger-Mathason TSK
Adv Exp Med Biol; 2019; 1136():57-69. PubMed ID: 31201716
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of advanced or metastatic melanoma.
Cebon J; Gedye C; John T; Davis ID
Clin Adv Hematol Oncol; 2007 Dec; 5(12):994-1006. PubMed ID: 18277962
[TBL] [Abstract][Full Text] [Related]
16. Immunological Regulation of Vascular Inflammation During Cancer Metastasis.
McDowell SAC; Quail DF
Front Immunol; 2019; 10():1984. PubMed ID: 31497019
[TBL] [Abstract][Full Text] [Related]
17. Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis.
Kähkönen TE; Halleen JM; Bernoulli J
Cells; 2021 Jun; 10(6):. PubMed ID: 34204474
[TBL] [Abstract][Full Text] [Related]
18. Targeting metastatic cancer.
Ganesh K; Massagué J
Nat Med; 2021 Jan; 27(1):34-44. PubMed ID: 33442008
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and Significance of the Pre-metastatic Niche.
Liu Y; Cao X
Cancer Cell; 2016 Nov; 30(5):668-681. PubMed ID: 27846389
[TBL] [Abstract][Full Text] [Related]
20. Informing the new developments and future of cancer immunotherapy : Future of cancer immunotherapy.
Kumar A; Swain CA; Shevde LA
Cancer Metastasis Rev; 2021 Jun; 40(2):549-562. PubMed ID: 34003425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
